Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of Disease Study 2019. Lancet Public Heal. 2022;7:e105–25. https://doi.org/10.1016/s2468-2667(21)00249-8.

Article  Google Scholar 

Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396:413–46. https://doi.org/10.1016/S0140-6736(20)30367-6.

Article  PubMed  PubMed Central  Google Scholar 

Chowdhary N, Barbui C, Anstey KJ, Kivipelto M, Barbera M, Peters R, et al. Reducing the risk of Cognitive decline and Dementia: WHO recommendations. Front Neurol. 2022;12:1–7. https://doi.org/10.3389/fneur.2021.765584.

Article  Google Scholar 

Fu J, Tan LJ, Lee JE, Shin S. Association between the mediterranean diet and cognitive health among healthy adults: a systematic review and meta-analysis. Front Nutr 2022;9. https://doi.org/10.3389/fnut.2022.946361.

Papadaki A, Nolen-Doerr E, Mantzoros CS. The effect of the mediterranean diet on metabolic health: a systematic review and meta-analysis of controlled trials in adults. Nutrients. 2020;12:1–21. https://doi.org/10.3390/nu12113342.

Article  CAS  Google Scholar 

Kao YC, Ho PC, Tu YK, Jou IM, Tsai KJ. Lipids and alzheimer’s disease. Int J Mol Sci. 2020;21:1–37. https://doi.org/10.3390/ijms21041505.

Article  CAS  Google Scholar 

Chiurchiù V, Tiberi M, Matteocci A, Fazio F, Siffeti H, Saracini S, et al. Lipidomics of bioactive lipids in Alzheimer’s and Parkinson’s diseases: where are we? Int J Mol Sci. 2022;23. https://doi.org/10.3390/ijms23116235.

Zarrouk A, Debbabi M, Bezine M, Karym EM, Badreddine A, Rouaud O, et al. Lipid biomarkers in Alzheimer’s Disease. Curr Alzheimer Res. 2018;15:303–12. https://doi.org/10.2174/1567205014666170505101426.

Article  CAS  PubMed  Google Scholar 

Sims R, Hill M, Williams J. The multiplex model of the genetics of Alzheimer’s disease. Nat Neurosci. 2020;23:311–22. https://doi.org/10.1038/s41593-020-0599-5.

Article  CAS  PubMed  Google Scholar 

Liao F, Yoon H, Kim J. Apolipoprotein e metabolism and functions in brain and its role in Alzheimer’s disease. Curr Opin Lipidol. 2017;28:60–7. https://doi.org/10.1097/MOL.0000000000000383.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cristino L, Bisogno T, Di Marzo V. Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nat Rev Neurol. 2020;16:9–29. https://doi.org/10.1038/s41582-019-0284-z.

Article  PubMed  Google Scholar 

Busquets-García A, Bolaños JP, Marsicano G. Metabolic messengers: endocannabinoids. Nat Metab. 2022;4:848–55. https://doi.org/10.1038/s42255-022-00600-1.

Article  PubMed  Google Scholar 

Bisogno T, Maccarrone M. Endocannabinoid signaling and its regulation by nutrients. BioFactors. 2014;40:373–80. https://doi.org/10.1002/biof.1167.

Article  CAS  PubMed  Google Scholar 

Kruk-Slomka M, Dzik A, Budzynska B, Biala G. Endocannabinoid System: the direct and indirect involvement in the memory and learning Processes—a. Short Rev Mol Neurobiol. 2017;54:8332–47. https://doi.org/10.1007/s12035-016-0313-5.

Article  CAS  Google Scholar 

Fagundo AB, de la Torre R, Jiménez-Murcia S, Agüera Z, Pastor A, Casanueva FF, et al. Modulation of the endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on executive functions in humans. PLoS ONE. 2013;8:66387. https://doi.org/10.1371/JOURNAL.PONE.0066387.

Article  Google Scholar 

La Porta C, Andreea Bura S, Llorente-Onaindia J, Pastor A, Navarrete F, García-Gutierrez MS, et al. Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain. Pain. 2015;156:2001–12. https://doi.org/10.1097/j.pain.0000000000000260.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Forte N, Fernández-Rilo AC, Palomba L, Marfella B, Piscitelli F, De Girolamo P, et al. Positive association between plasmatic levels of orexin A and the endocannabinoid-derived 2-arachidonoyl lysophosphatidic acid in Alzheimer’s disease. Front Aging Neurosci. 2022;14:1–14. https://doi.org/10.3389/fnagi.2022.1004002.

Article  CAS  Google Scholar 

Berry AJ, Zubko O, Reeves SJ, Howard RJ. Endocannabinoid system alterations in Alzheimer’s disease: a systematic review of human studies. Brain Res. 2020;1749:147135. https://doi.org/10.1016/j.brainres.2020.147135.

Article  CAS  PubMed  Google Scholar 

Hillard CJ. Circulating endocannabinoids: from Whence do they come and where are they. Going? Neuropsychopharmacol. 2018;43:155–72. https://doi.org/10.1038/npp.2017.130.

Article  CAS  Google Scholar 

Tagliamonte S, Laiola M, Ferracane R, Vitale M, Gallo MA, Meslier V, et al. Mediterranean diet consumption affects the endocannabinoid system in overweight and obese subjects: possible links with gut microbiome, insulin resistance and inflammation. Eur J Nutr. 2021;60:3703–16. https://doi.org/10.1007/s00394-021-02538-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Soldevila-Domenech N, Pastor A, Sala-Vila A, Lázaro I, Boronat A, Muñoz D, et al. Sex differences in endocannabinoids during 3 years of Mediterranean diet intervention: Association with insulin resistance and weight loss in a population with metabolic syndrome. Front Nutr. 2022;9. https://doi.org/10.3389/fnut.2022.1076677.

Asaro A, Carlo-Spiewok AS, Malik AR, Rothe M, Schipke CG, Peters O, et al. Apolipoprotein E4 disrupts the neuroprotective action of sortilin in neuronal lipid metabolism and endocannabinoid signaling. Alzheimer’s Dement. 2020;16:1248–58. https://doi.org/10.1002/alz.12121.

Article  Google Scholar 

Soldevila-Domenech N, Forcano L, Vintró-Alcaraz C, Cuenca-Royo A, Pintó X, Jiménez-Murcia S, et al. Interplay between cognition and weight reduction in individuals following a Mediterranean Diet: three-year follow-up of the PREDIMED-Plus trial. Clin Nutr. 2021;40:5221–37. https://doi.org/10.1016/j.clnu.2021.07.020.

Article  CAS  PubMed  Google Scholar 

Solomon A, Turunen H, Ngandu T, Peltonen M, Levälahti E, Helisalmi S, et al. Effect of the apolipoprotein e genotype on cognitive change during a multidomain lifestyle intervention a subgroup analysis of a randomized clinical trial. JAMA Neurol. 2018;75:462–70. https://doi.org/10.1001/jamaneurol.2017.4365.

Article  PubMed  PubMed Central  Google Scholar 

González-Domínguez R, Castellano-Escuder P, Lefèvre-Arbogast S, Low DY, Du Preez A, Ruigrok SR, et al. Apolipoprotein E and sex modulate fatty acid metabolism in a prospective observational study of cognitive decline. Alzheimer’s Res Ther. 2022;14:1–12. https://doi.org/10.1186/s13195-021-00948-8.

Article  CAS  Google Scholar 

Arnold M, Nho K, Kueider-Paisley A, Massaro T, Huynh K, Brauner B, et al. Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome. Nat Commun. 2020;11. https://doi.org/10.1038/s41467-020-14959-w.

Lim WLF, Huynh K, Chatterjee P, Martins I, Jayawardana KS, Giles C, et al. Relationships between plasma lipids species, gender, risk factors, and Alzheimer’s Disease. J Alzheimer’s Dis. 2020;76:303–15. https://doi.org/10.3233/JAD-191304.

Article  CAS  Google Scholar 

Yassine HN, Samieri C, Livingston G, Glass K, Wagner M, Tangney C, et al. Nutrition state of science and dementia prevention: recommendations of the Nutrition for Dementia Prevention Working Group. Lancet Heal Longev. 2022;3:e501–12. https://doi.org/10.1016/S2666-7568(22)00120-9.

Article  Google Scholar 

Ferretti MT, Martinkova J, Biskup E, Benke T, Gialdini G, Nedelska Z, et al. Sex and gender differences in Alzheimer’s disease: current challenges and implications for clinical practice: position paper of the Dementia and Cognitive disorders Panel of the European Academy of Neurology. Eur J Neurol. 2020;27:928–43. https://doi.org/10.1111/ene.14174.

Article  CAS  PubMed  Google Scholar 

Reiman EM, Arboleda-Velasquez JF, Quiroz YT, Huentelman MJ, Beach TG, Caselli RJ, et al. Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat Commun. 2020;11. https://doi.org/10.1038/S41467-019-14279-8.

Yamazaki Y, Zhao N, Caulfield TR, Liu CC, Bu G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol. 2019;15:501–18. https://doi.org/10.1038/S41582-019-0228-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martínez-González MA, Buil-Cosiales P, Corella D, Bulló M, Fitó M, Vioque J et al. Cohort profile: Design and methods of the PREDIMED-Plus randomized trial. Int J Epidemiol. 2019;48:387-388o. https://doi.org/10.1093/ije/dyy225.

Sayón-Orea C, Razquin C, Bulló M, Corella D, Fitó M, Romaguera D, et al. Effect of a nutritional and behavioral intervention on Energy-reduced Mediterranean Diet Adherence among patients with metabolic syndrome: interim analysis of the PREDIMED-Plus Randomized Clinical Trial. JAMA. 2019;322:1486–99. https://doi.org/10.1001/jama.2019.14630.

Article  PubMed  PubMed Central